A systematic review on malaria and dengue vaccines for the effective management of these mosquito borne diseases: Improving public health.
Gespeichert in:
| Titel: | A systematic review on malaria and dengue vaccines for the effective management of these mosquito borne diseases: Improving public health. |
|---|---|
| Autoren: | Al-Osaimi HM; Department of Pharmacy Services Administration, King Fahad Medical City, Riyadh Second Health Cluster, Riyadh, Kingdom of Saudi Arabia., Kanan M; Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia., Marghlani L; Department of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia., Al-Rowaili B; Pharmaceutical Services Department, Northern Area Armed Forces Hospital, King Khalid Military, Hafr Al Batin, Kingdom of Saudi Arabia., Albalawi R; Department of Medicine, Tabuk University, Tabuk, Kingdom of Saudi Arabia., Saad A; Pharmacy Department, Royal Commission Hospital, Yanbu, Kingdom of Saudi Arabia., Alasmari S; Department of Clinical Pharmacy, King Khalid University, Jeddah, Kingdom of Saudi Arabia., Althobaiti K; Department of Medicine, Taif University, Ta'if, Kingdom of Saudi Arabia., Alhulaili Z; Department of Clinical Pharmacy, Dammam Medical Complex, Dammam, Kingdom of Saudi Arabia., Alanzi A; Department of Medicine, King Abdulaziz Hospital, Makkah, Kingdom of Saudi Arabia., Alqarni R; Department of Medicine and Surgery, King Khalid University, Abha, Kingdom of Saudi Arabia., Alsofiyani R; Department of Medicine, Taif University, Ta'if, Kingdom of Saudi Arabia., Shrwani R; Department of Clinical Pharmacy, Jazan University, Jazan, Kingdom of Saudi Arabia. |
| Quelle: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2337985. Date of Electronic Publication: 2024 Apr 11. |
| Publikationsart: | Journal Article; Systematic Review |
| Sprache: | English |
| Info zur Zeitschrift: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2015- : Philadelphia, PA : Taylor & Francis Original Publication: Austin, Tex. : Landes Bioscience |
| MeSH-Schlagworte: | Dengue*/prevention & control , Dengue Vaccines* , Malaria*/prevention & control , Mosquito-Borne Diseases*, Animals ; Public Health ; Humans |
| Abstract: | Insect vector-borne diseases (VBDs) pose significant global health challenges, particularly in tropical and subtropical regions. The WHO has launched the "Global Vector Control Response (GVCR) 2017-2030" to address these diseases, emphasizing a comprehensive approach to vector control. This systematic review investigates the potential of malaria and dengue vaccines in controlling mosquito-borne VBDs, aiming to alleviate disease burdens and enhance public health. Following PRISMA 2020 guidelines, the review incorporated 39 new studies out of 934 identified records. It encompasses various studies assessing malaria and dengue vaccines, emphasizing the significance of vaccination as a preventive measure. The findings indicate variations in vaccine efficacy, duration of protection, and safety considerations for each disease, influencing public health strategies. The review underscores the urgent need for vaccines to combat the increasing burden of VBDs like malaria and dengue, advocating for ongoing research and investment in vaccine development. |
| References: | Clin Lab Med. 2010 Mar;30(1):93-129. (PMID: 20513543) Glob Health Action. 2014 Oct 10;7:25287. (PMID: 25308818) J Infect Dis. 2013 Aug 1;208(3):479-88. (PMID: 23624363) N Engl J Med. 2008 Dec 11;359(24):2521-32. (PMID: 19064627) Infect Dis Poverty. 2018 Sep 03;7(1):90. (PMID: 30173661) Lancet Infect Dis. 2022 Dec;22(12):1728-1736. (PMID: 36087586) Lancet Infect Dis. 2011 Oct;11(10):741-9. (PMID: 21782519) Lancet. 2014 Oct 11;384(9951):1358-65. (PMID: 25018116) Front Public Health. 2021 Oct 05;9:715759. (PMID: 34676194) Vaccine. 2020 Sep 22;38(41):6472-6477. (PMID: 32773243) Vaccine. 2012 Sep 7;30(41):5935-41. (PMID: 22863660) Clin Infect Dis. 2022 Aug 24;75(1):107-117. (PMID: 34606595) N Engl J Med. 2012 Dec 13;367(24):2284-95. (PMID: 23136909) Vaccine. 2013 Dec 2;31(49):5814-21. (PMID: 24135573) Vaccine. 2004 Mar 12;22(9-10):1188-98. (PMID: 15003647) Trop Med Infect Dis. 2022 Jul 04;7(7):. (PMID: 35878137) Lancet. 2021 May 15;397(10287):1809-1818. (PMID: 33964223) N Engl J Med. 2015 Nov 19;373(21):2025-2037. (PMID: 26488565) PLoS Negl Trop Dis. 2020 Jan 16;14(1):e0007831. (PMID: 31945061) Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165689. (PMID: 32001300) N Engl J Med. 2008 Dec 11;359(24):2533-44. (PMID: 19064623) Expert Rev Vaccines. 2003 Apr;2(2):231-8. (PMID: 12899574) Front Microbiol. 2013 Nov 19;4:337. (PMID: 24312085) Pediatr Infect Dis J. 2013 Oct;32(10):1102-9. (PMID: 24067553) Ther Adv Vaccines Immunother. 2021 May 17;9:25151355211015839. (PMID: 34036241) Lancet Infect Dis. 2010 Aug;10(8):545-55. (PMID: 20637696) Expert Rev Vaccines. 2011 May;10(5):589-99. (PMID: 21604980) Am J Trop Med Hyg. 2013 Dec;89(6):1058-1065. (PMID: 24189367) Rev Saude Publica. 2005 Jun;39(3):413-20. (PMID: 15997317) BMJ. 2021 Mar 29;372:n71. (PMID: 33782057) N Engl J Med. 2015 Jan 8;372(2):113-23. (PMID: 25365753) PLoS One. 2009 Jul 31;4(7):e6465. (PMID: 19649245) Am J Trop Med Hyg. 2002 May;66(5):533-41. (PMID: 12201587) Lancet. 2016 Jan 23;387(10016):367-375. (PMID: 26549466) PLoS One. 2011;6(7):e22525. (PMID: 21829466) Hum Vaccin Immunother. 2014;10(8):2211-9. (PMID: 25424924) Nature. 2013 Apr 25;496(7446):504-7. (PMID: 23563266) J Infect Dis. 2016 May 15;213(10):1562-72. (PMID: 26704612) Hum Vaccin Immunother. 2017 Jan 2;13(1):19-33. (PMID: 27636098) Lancet Infect Dis. 2020 Jul;20(7):839-850. (PMID: 32220283) Am J Med Sci. 1973 Sep;266(3):169-77. (PMID: 4583408) Nature. 2002 Feb 7;415(6872):680-5. (PMID: 11832956) Vaccine. 2011 Sep 23;29(42):7251-60. (PMID: 21777638) N Engl J Med. 1997 Jan 9;336(2):86-91. (PMID: 8988885) Vaccine. 2015 Dec 10;33(50):7100-11. (PMID: 26475445) PLoS One. 2009 Oct 27;4(10):e7611. (PMID: 19859560) Hum Vaccin Immunother. 2020 Mar 3;16(3):480-489. (PMID: 31545128) Mol Ther. 2016 Aug;24(8):1470-7. (PMID: 27109630) Am J Trop Med Hyg. 1991 Nov;45(5):533-8. (PMID: 1835311) Vaccine. 2009 Nov 16;27(49):6862-8. (PMID: 19755144) J Infect Dis. 2009 Aug 1;200(3):337-46. (PMID: 19569965) Vaccine. 2010 Sep 24;28(41):6698-703. (PMID: 20696154) Vaccines (Basel). 2021 Sep 24;9(10):. (PMID: 34696180) J Infect Dis. 2009 Aug 1;200(3):329-36. (PMID: 19569964) Lancet Infect Dis. 2011 Feb;11(2):102-9. (PMID: 21237715) Curr Top Microbiol Immunol. 2010;338:1-13. (PMID: 19802574) Front Immunol. 2022 Jun 28;13:908398. (PMID: 35837409) N Engl J Med. 2011 Nov 17;365(20):1863-75. (PMID: 22007715) Res Synth Methods. 2021 Jan;12(1):55-61. (PMID: 32336025) Front Immunol. 2017 Aug 04;8:863. (PMID: 28824613) J Family Med Prim Care. 2019 Oct 31;8(10):3125-3129. (PMID: 31742130) Hum Vaccin Immunother. 2019;15(10):2295-2314. (PMID: 31589551) Mem Inst Oswaldo Cruz. 2010 Feb;105(1):1-12. (PMID: 20209323) Lancet. 2007 Nov 3;370(9598):1543-51. (PMID: 17949807) PLoS Negl Trop Dis. 2021 Mar 12;15(3):e0009258. (PMID: 33711074) PLoS One. 2009 Oct 02;4(10):e7302. (PMID: 19806184) Cell. 2006 Feb 24;124(4):783-801. (PMID: 16497588) PLoS Negl Trop Dis. 2013;7(2):e2055. (PMID: 23437406) PLoS Med. 2007 Nov 13;4(11):e320. (PMID: 18001147) Infect Immun. 2000 May;68(5):2617-20. (PMID: 10768952) Vaccine. 2011 Sep 23;29(42):7229-41. (PMID: 21745521) PLoS Med. 2014 Jul 29;11(7):e1001685. (PMID: 25072396) J Infect Dis. 2001 Feb 15;183(4):640-7. (PMID: 11170991) PLoS One. 2009;4(4):e5165. (PMID: 19365567) J Vector Borne Dis. 2014 Sep;51(3):153-64. (PMID: 25253207) Pathogens. 2020 Apr 23;9(4):. (PMID: 32340230) Am J Trop Med Hyg. 2019 Feb;100(2):242-245. (PMID: 30499427) BMC Med. 2015 Oct 01;13:249. (PMID: 26423147) Malar J. 2011 Aug 04;10:224. (PMID: 21816029) J Infect Dis. 2015 Sep 1;212(5):702-10. (PMID: 25801652) BMC Med. 2015 Feb 03;13:23. (PMID: 25644195) Hum Vaccin Immunother. 2019;15(10):2315-2327. (PMID: 30724660) N Engl J Med. 2018 Jul 26;379(4):327-340. (PMID: 29897841) Nat Med. 2021 Aug;27(8):1395-1400. (PMID: 34168334) J Immunol. 2007 Sep 15;179(6):4193-201. (PMID: 17785859) Hum Vaccin. 2010 Sep 16;6(9):. (PMID: 20861669) Sci Rep. 2017 Apr 19;7:46621. (PMID: 28422178) Lancet Infect Dis. 2016 Oct;16(10):1134-1144. (PMID: 27394191) J Infect Dis. 2022 May 4;225(9):1521-1532. (PMID: 33319249) PLoS Med. 2004 Nov;1(2):e33. (PMID: 15526058) J Infect Dis. 2013 Mar 15;207(6):957-65. (PMID: 23329850) Lancet Infect Dis. 2015 Jun;15(6):721-30. (PMID: 25808458) Lancet Infect Dis. 2005 Nov;5(11):695-708. (PMID: 16253887) Vector Borne Zoonotic Dis. 2020 Mar;20(3):159-170. (PMID: 31800374) Lancet. 2001 Dec 8;358(9297):1927-34. (PMID: 11747915) J Infect Dis. 1998 Oct;178(4):1139-44. (PMID: 9806046) BMJ. 2009 Oct 19;339:b4012. (PMID: 19841007) Elife. 2020 Apr 29;9:. (PMID: 32342859) Lancet. 2012 Nov 3;380(9853):1559-67. (PMID: 22975340) Curr Opin Virol. 2020 Aug;43:79-87. (PMID: 33164790) Lancet. 2015 Jul 4;386(9988):31-45. (PMID: 25913272) N Engl J Med. 2013 Mar 21;368(12):1111-20. (PMID: 23514288) Vaccine. 2007 Jul 20;25(29):5359-66. (PMID: 17574311) Nat Rev Microbiol. 2016 Jan;14(1):45-54. (PMID: 26639777) Vaccine. 2016 Aug 31;34(38):4536-4542. (PMID: 27477844) FEMS Microbiol Lett. 2018 Feb 1;365(2):. (PMID: 29149298) FEMS Microbiol Rev. 2022 Feb 9;46(1):. (PMID: 34550355) Sci Transl Med. 2015 May 06;7(286):286re5. (PMID: 25947165) Vaccine. 2017 Oct 9;35(42):5535-5542. (PMID: 28893477) |
| Contributed Indexing: | Keywords: Systematic review; effective management; improving public health; insect vector-borne diseases; vaccines |
| Substance Nomenclature: | 0 (Dengue Vaccines) |
| Entry Date(s): | Date Created: 20240411 Date Completed: 20240412 Latest Revision: 20241126 |
| Update Code: | 20250114 |
| PubMed Central ID: | PMC11017952 |
| DOI: | 10.1080/21645515.2024.2337985 |
| PMID: | 38602074 |
| Datenbank: | MEDLINE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstract: | Insect vector-borne diseases (VBDs) pose significant global health challenges, particularly in tropical and subtropical regions. The WHO has launched the "Global Vector Control Response (GVCR) 2017-2030" to address these diseases, emphasizing a comprehensive approach to vector control. This systematic review investigates the potential of malaria and dengue vaccines in controlling mosquito-borne VBDs, aiming to alleviate disease burdens and enhance public health. Following PRISMA 2020 guidelines, the review incorporated 39 new studies out of 934 identified records. It encompasses various studies assessing malaria and dengue vaccines, emphasizing the significance of vaccination as a preventive measure. The findings indicate variations in vaccine efficacy, duration of protection, and safety considerations for each disease, influencing public health strategies. The review underscores the urgent need for vaccines to combat the increasing burden of VBDs like malaria and dengue, advocating for ongoing research and investment in vaccine development. |
|---|---|
| ISSN: | 2164-554X |
| DOI: | 10.1080/21645515.2024.2337985 |